Pharma News

The U.S. Food and Drug Administration  approved Defitelio (defibrotide sodium) to treat adults and children who develop hepatic veno-occlusive disease (VOD) with additional kidney or lung abnormalities after they receive a stem cell transplant from blood or bone marrow called hematopoietic stem cell transplantation (HSCT). This is the first FDA-approved therapy for treatment of severe hepatic VOD, a rare and life-threatening liver condition. Defitelio is marketed by Jazz Pharmaceuticals based in Palo Alto, California.

The U.S. Food and Drug Administration today announced the availability of an investigational test to screen blood donations for Zika virus. The screening test may be used under an investigational new drug application (IND) for screening donated blood in areas with active mosquito-borne transmission of Zika virus. The test is manufactured by Roche Molecular Systems, Inc., based in Branchburg, New Jersey.

Natco Pharma decided to sales its US based pharmacy store. Natco decided in thier board meeting to sale of its Save Mart Store in the USA.

Adaptimmune Therapeutics plc announced that the U.S. Food and Drug Administration (FDA)'s Office of Orphan Products Development has granted orphan drug designation for the company’s affinity enhanced T-cell therapy targeting NY-ESO for the treatment of soft tissue sarcoma, a solid tumor cancer.

A drug used in the treatment of diabetes can increase the risk of bladder cancer, warns a new study adding that the risk increases with the rising duration of use and the dose.

The rising cost of raw materials, stringent regulatory requirements and increasingly competitive environment all are rapidly eroding the profit margins of many antibiotic manufacturers. BCC Research reveals in its new report that these challenges, and the growing problem of antibiotic resistance, have dramatically shifted the business models of some of the industry’s leading pharmaceutical companies.

Opening the door for new detection method that could allow doctors to diagnose patients with certain cancers far earlier than possible today, researchers have developed an optical sensor that they claim is one million times more sensitive than the current best available.

In a major advance towards a universal flu jab which would protect people against all strains of the virus, researchers have developed a new vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.

Using a nanoparticle that delivers a drug and then glows green when cancer cells begin dying, Indian origin researchers have found a way to detect the effectiveness of cancer treatment much sooner than currently available clinical methods.